Clinical Trial Update: Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) [Phase 1]

View source ↗

Summary

Phase 1 safety trial of the MVA Smallpox Vaccine in people with a history of atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Smallpox

Drugs mentioned

• MVA Smallpox Vaccine (Modified vaccinia Ankara smallpox vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Smallpox, Atopic Dermatitis | Phase 1 | Status: WITHDRAWN